Dysprosium ions promote osteogenic differentiation accompanied by β-catenin/runX2 activation and enhance osteogenesis in combination with strontium ions
Frontiers in Bioengineering and Biotechnology · 20.11.2026 · 14
DOI: 10.3389/fbioe.2026.1999346 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 20.11.2026. Verfasst von Huanqing Zhang und 10 weiteren Autor:innen. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Dysprosium (Dy) is a rare earth element that has been confirmed to enhance osteogenesis and applied in the synthesis. However, its osteogenic effects, optimal concentration, and potential combined effects with other metal ions, such as Sr 2+ , remain poorly understood.
Methods
MC3T3-E1 cells were treated with Dy 3+ (10 −7 –10 −3 M), alone or combined with Sr 2+ (500 μM). Cell viability, osteogenic differentiation, and protein expression were assessed, and intracellular elemental distribution was examined by TEM/EDS.
Results
Dy 3+ at 10 −7 –10 −3 M did not significantly reduce cell viability up to day 7. However, a concentration-dependent trade-off was observed: 10 −6 M Dy 3+ promoted proliferation but exhibited poor osteogenic induction, whereas 10 −3 M Dy 3+ enhanced osteogenesis at the expense of proliferative activity. Notably, 10 −6 M Dy 3+ combined with Sr 2+ produced a greater osteogenic effect than Sr 2+ alone. Mechanistically, the co-treatment was accompanied by the upregulation of the β-catenin/RunX2 signaling axis and increased the expression of osteogenic markers (OPN, OCN, COL1A1). TEM/EDS revealed that Dy co-localized with calcium/phosphorus-rich deposits.
Conclusion
Dy 3+ exhibits good biocompatibility over a broad concentration range but shows a good osteogenesis induction at high concentration. Its combination with Sr 2+ yields enhanced osteogenic effects along with the upregulation of the β-catenin/RunX2 axis, highlighting the potential of Dy 3+ /Sr 2+ co-application in bone regenerative biomaterials.
Zitieren
APA
Zhang, H., Sun, M., Gao, X., Lu, X., Meng, H., Liu, Y., Xu, Z., Chen, C., Chen, L., Xu, Y., & Sun, J. (2026). Dysprosium ions promote osteogenic differentiation accompanied by β-catenin/runX2 activation and enhance osteogenesis in combination with strontium ions. Frontiers in Bioengineering and Biotechnology, 14. https://doi.org/10.3389/fbioe.2026.1999346
Vancouver
Zhang H, Sun M, Gao X, Lu X, Meng H, Liu Y, et al. Dysprosium ions promote osteogenic differentiation accompanied by β-catenin/runX2 activation and enhance osteogenesis in combination with strontium ions. Frontiers in Bioengineering and Biotechnology. 2026;14. doi:10.3389/fbioe.2026.1999346
BibTeX
@article{Zhang2026,
author = {Zhang, Huanqing and Sun, Ming and Gao, Xiaohan and Lu, Xiaoyun and Meng, Hao and Liu, Yanshan and Xu, Zexian and Chen, Chen and Chen, Liqiang and Xu, Yaoxiang and Sun, Jian},
title = {Dysprosium ions promote osteogenic differentiation accompanied by β-catenin/runX2 activation and enhance osteogenesis in combination with strontium ions},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2026},
volume = {14},
doi = {10.3389/fbioe.2026.1999346}
}
EUVIMED